ImmunAbs Inc.

General Information

Company Name

ImmunAbs Inc.

Founded Year

2017

Location (Offices)

Founders / Decision Makers

Number of Employees

Industries

Biotechnology, Health Care, Health and Wellness

Funding Stage

Series B

Social Media

ImmunAbs Inc. - Company Profile

ImmunAbs Inc. is a biotech venture specializing in the development of specialized antibody pharmaceuticals to provide hope for patients and dreams for all. The company has made significant strides in the field of antibody-based therapeutics for patients with autoimmune diseases. In April 2024, ImmunAbs successfully completed a Phase 1 clinical trial in the United States and is now gearing up for a Phase 2 clinical trial. Founded in 2017, the company aspires to become a global leader in biopharmaceuticals, as indicated by their powerful motto: 'Hope for patients, dreams for all'. Their latest boost came in the form of a Series B investment at 31 October 2021 from Nice Investment Partners, marking a vital milestone in their journey. For further information, individuals can contact Sabrina Pan via her LinkedIn profile.

Taxonomy: Biotech, Pharmaceuticals, Antibody-based Therapeutics, Autoimmune Diseases, Clinical Trials, Biopharmaceuticals, Medical Research, Healthcare Innovation, Drug Development, Therapeutic Antibodies, Biomedical Science, Global Health, Innovative Medicine, Patient Care